Why the study?
Digital health technologies offer unprecedented opportunities to address the global burden of chronic diseases, but their effectiveness, implementation challenges, and future directions require synthesis.
Do digital health technologies improve clinical outcomes and prevention in patients with or at risk for chronic diseases?
Design
Narrative review of peer-reviewed literature published between 2020 and 2025
Key result
Mobile health interventions for chronic disease prevention improved glycemic control, yielding a mean HbA1c reduction of -0.49% (95% CI -0.65% to -0.32%) compared to standard care.
Authors
Loading...
May support selective adoption in diabetes care pathways; confirms benefits across large analyses but leaves open equity and integration barriers.
Do digital health technologies improve clinical outcomes and prevention in patients with or at risk for chronic diseases?
Effect estimate: Mean reduction -0.49% (95% CI -0.65% to -0.32%)
Digital health technologies offer significant potential for chronic disease prevention and management, but widespread implementation requires addressing critical barriers related to health equity and system integration.
Ahmed Abdulaziz Almohammadi (2026) conducted a review in Chronic diseases (diabetes, cardiovascular disease, obesity). Digital health technologies (mobile health, wearables, telemedicine, AI) vs. Standard care was evaluated on HbA1c reduction (Mean reduction -0.49%, 95% CI -0.65% to -0.32%). Mobile health interventions for chronic disease prevention improved glycemic control, yielding a mean HbA1c reduction of -0.49% (95% CI -0.65% to -0.32%) compared to standard care.